Functional Outcomes and Control Using Synchron BCI - Australia (FOCUS-AUS)

ClinicalTrials.gov has posted a new registry entry for the FOCUS-AUS study, a clinical trial evaluating Synchron's Stentrode brain-computer interface device. The study targets patients with motor neuron disease, amyotrophic lateral sclerosis, and paralysis. The Stentrode is an endovascular electrode array designed to record neural signals from the motor cortex.

Affected parties include patients with neurologic disorders and paralysis, clinical investigators conducting the trial in Australia, and medical device manufacturers developing brain-computer interface technologies. Trial sponsors and clinical sites should register the study in applicable national registries and adhere to local regulatory requirements for device clinical investigations.